USPTO serial 79420986
UNVEIL-IT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 4, 2026
- Examiner
- BROWNE, LUCY E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with UNVEIL-IT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronald M. Kachmarik
Ronald M. Kachmarik Cooper Legal Group LLC1388 Ridge Road, Unit 1Hinckley, OH 44233United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Compilation of information being medical reports into databanks; | ACTIVE | — |
| 042 | Scientific research for medical purposes in the field of pharmaceuticals; pharmaceutical research and development services; medical and scientific research, namely conducting of clinical trials for others for determining the efficacy and safety of pharmaceutical products in the treatment of acute liver decompensation and acute-on-chronic liver failure (ACLF); scientific research, namely, conducting scientific studies and analyses in the field of pharmaceuticals and development of pharmaceutical products; providing scientific research information, results and data relating to scientific or medical research and development of pharmaceutical products, especially from an online searchable database; medical and scientific research, namely, conducting clinical trials for others; scientific research, namely, pharmaceutical and biological development and research services for third parties; scientific clinical research; scientific research, namely, evaluation of the efficacy of pharmaceutical products; clinical development services, namely, clinical pharmaceutical development of pharmaceutical drug products | ACTIVE | — |
| 044 | Advisory services relating to health and medical care; medical information; medical information services provided via the Internet; medical diagnosis services, namely, performing diagnosis of diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 9, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 4, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 4, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 28, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 28, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 1, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 31, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 10, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |